SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarey Drugs & Pharmaceuticals informs outcome of board meeting

31 Dec 2012 Evaluate

Aarey Drugs & Pharmaceuticals has informed that the board of directors of the company at its meeting held on December 29, 2012, has approved the reappointment of Mihir Rajesh Ghatalia as the managing director of the company for a further period of three years from December 31, 2012 to December 30, 2015, subject to the approval of the shareholders at the next annual general meeting.

The above information is a part of company’s filings submitted to BSE.

Aarey Drugs & Pharma Share Price

68.65 2.97 (4.52%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 220.95
Adani Enterprises 2088.20
Amrapali Industries 17.32
Rashi Peripheral 404.30
PDS 295.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×